The Week in Review

MindMed Developing IP For Personalized Psychedelic Assisted Therapies

Recently we’ve seen ATAI and Eleusis put forth patent strategies that include psychedelics in combination with digital therapeutics and patient screening measures, respectively.

This week MindMed announced IP meant to personalize the dosing of psychedelic therapy:

“Mind Medicine… is deve…

This post is for paying subscribers